“In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017” is the new market research report added to ReportsnReports.com store.
Dallas, Texas (PRWEB) July 30, 2013
The global in vitro diagnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.
The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.
The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market.
In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market (http://www.reportsnreports.com/reports/266706-in-vitro-diagnostic-ivd-market-instruments-reagents-data-management-systems-technique-immunoassay-clinical-chemistry-molecular-diagnostics-haematology-applications-diabetes-infectious-diseases-cancer-cardiology-systems-end-users-forecast-to-2017.html), followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.
Scope of the Report
This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels.
Global IVD Market, by Technique:
· Immunochemistry
· Clinical Chemistry
· Molecular Diagnostics
· Hematology
· Microbiology
· Coagulation
· Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry)
Global IVD Market, by Product Type:
· Reagents
· Instruments
· Services
· Data Management System Software/Hardware
Global IVD Market, by Application:
· Diabetes
· Infectious Diseases
· Oncology
· Cardiology
· HIV/AIDS
· Autoimmune Diseases
· Drug Testing
· Nephrology
· Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications)
Global IVD Market (http://www.reportsnreports.com/tags/ivd-market-research.html), by End-Users:
· Hospitals
· Laboratories
· Patient Self-testing
· POCT (Point-of-Care Testing)
· Academics (academic medical centers/research laboratories, university laboratories, etc.)
· Others (blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical centers)
In Vitro Diagnostic Market, by Geography:
· The Americas
· U.S.
· Canada
· Mexico
· Chile
· Rest of America
· Europe
· Germany
· France
· Italy
· Spain
· U.K.
· Rest of Europe
· Japan
· BRIC
· Brazil
· Russia
· India
· China
· Rest of the World
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=266706; alternatively they can get discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=266706.
Company Profiles (Overview, Financials, Products & Services, Developments & Strategy):
1. Abbott Laboratories, Inc.
2. Alere, Inc.
3. Arkray, Inc.
4. Bayer AG
5. Becton, Dickinson And Company
6. Biomerieux
7. Bio-Rad Laboratories, Inc.
8. Danaher Corporation
9. Diagnostica Stago Sas
10. Diasorin S.P.A.
11. Hologic, Inc.
12. Horiba, Ltd.
13. Johnson & Johnson
14. Novartis International Ag
15. Qiagen N.V.
16. Roche Diagnostics Limited
17. Siemens Healthcare
18. Sysmex Corporation
19. Thermo Fisher Scientific, Inc.
Explore more reports on Pharmaceutical Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
About US:
ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe. Reported by PRWeb 17 hours ago.
Dallas, Texas (PRWEB) July 30, 2013
The global in vitro diagnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.
The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.
The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market.
In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market (http://www.reportsnreports.com/reports/266706-in-vitro-diagnostic-ivd-market-instruments-reagents-data-management-systems-technique-immunoassay-clinical-chemistry-molecular-diagnostics-haematology-applications-diabetes-infectious-diseases-cancer-cardiology-systems-end-users-forecast-to-2017.html), followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.
Scope of the Report
This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels.
Global IVD Market, by Technique:
· Immunochemistry
· Clinical Chemistry
· Molecular Diagnostics
· Hematology
· Microbiology
· Coagulation
· Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry)
Global IVD Market, by Product Type:
· Reagents
· Instruments
· Services
· Data Management System Software/Hardware
Global IVD Market, by Application:
· Diabetes
· Infectious Diseases
· Oncology
· Cardiology
· HIV/AIDS
· Autoimmune Diseases
· Drug Testing
· Nephrology
· Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications)
Global IVD Market (http://www.reportsnreports.com/tags/ivd-market-research.html), by End-Users:
· Hospitals
· Laboratories
· Patient Self-testing
· POCT (Point-of-Care Testing)
· Academics (academic medical centers/research laboratories, university laboratories, etc.)
· Others (blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical centers)
In Vitro Diagnostic Market, by Geography:
· The Americas
· U.S.
· Canada
· Mexico
· Chile
· Rest of America
· Europe
· Germany
· France
· Italy
· Spain
· U.K.
· Rest of Europe
· Japan
· BRIC
· Brazil
· Russia
· India
· China
· Rest of the World
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=266706; alternatively they can get discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=266706.
Company Profiles (Overview, Financials, Products & Services, Developments & Strategy):
1. Abbott Laboratories, Inc.
2. Alere, Inc.
3. Arkray, Inc.
4. Bayer AG
5. Becton, Dickinson And Company
6. Biomerieux
7. Bio-Rad Laboratories, Inc.
8. Danaher Corporation
9. Diagnostica Stago Sas
10. Diasorin S.P.A.
11. Hologic, Inc.
12. Horiba, Ltd.
13. Johnson & Johnson
14. Novartis International Ag
15. Qiagen N.V.
16. Roche Diagnostics Limited
17. Siemens Healthcare
18. Sysmex Corporation
19. Thermo Fisher Scientific, Inc.
Explore more reports on Pharmaceutical Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
About US:
ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe. Reported by PRWeb 17 hours ago.